OcuTerra to Participate in Upcoming Investor Conferences
OcuTerra Therapeutics, Inc. (OcuTerra), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of watch-and-wait does not prevent or control the progression of disease, today announced the companys participation in two upcoming investor conferences.